| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0502F |
|
4,622 |
3,417 |
$213K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,446 |
1,977 |
$131K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
760 |
654 |
$58K |
| 76830 |
Ultrasound, transvaginal |
609 |
552 |
$43K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
531 |
507 |
$36K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
452 |
419 |
$30K |
| 76801 |
|
432 |
390 |
$30K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
784 |
581 |
$29K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
766 |
571 |
$28K |
| 87481 |
|
522 |
309 |
$27K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
345 |
308 |
$25K |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
28 |
13 |
$25K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
531 |
372 |
$21K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
732 |
570 |
$19K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
239 |
192 |
$18K |
| 87511 |
|
391 |
303 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
165 |
130 |
$13K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
325 |
263 |
$9K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
119 |
113 |
$8K |
| 0500F |
|
149 |
135 |
$6K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
72 |
52 |
$4K |
| 81025 |
|
1,141 |
933 |
$4K |
| 96127 |
|
137 |
109 |
$2K |
| 59025 |
Fetal non-stress test |
115 |
94 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
41 |
34 |
$1K |
| 86780 |
|
72 |
52 |
$1K |
| 76818 |
|
16 |
14 |
$1K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
17 |
17 |
$874.02 |
| 0503F |
|
14 |
12 |
$687.04 |
| 87653 |
|
12 |
12 |
$529.35 |
| 86803 |
|
25 |
14 |
$385.87 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
33 |
26 |
$301.17 |
| 87340 |
|
21 |
14 |
$255.16 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
41 |
37 |
$235.05 |
| 99459 |
|
12 |
12 |
$175.44 |
| 96160 |
|
12 |
12 |
$175.20 |
| 87210 |
|
14 |
14 |
$65.80 |
| 81002 |
|
14 |
13 |
$28.84 |